Effect of Rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease

American Journal of Cardiology

Volumn 96, Issue 9, 2005, Pages 1290-1292

  Verma, Anil ^a   Ranganna, Karthik M ^a   Reddy, Rani S ^a   Verma, Mandeep ^a   Gordon, Neil F ^b  

^a Candler Internal Medicine   (United States)

^b St Joseph's/Candler Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FLUOROBENZENES; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS, LDL; MALE; PROSPECTIVE STUDIES; PYRIMIDINES; SULFONAMIDES; TREATMENT OUTCOME;

EID: 27144534466     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.06.074     Document Type: Article

References (15)

1. B. Afzali, A.A. Haydar, K. Vinen, D.J.A. Goldsmith Beneficial effects of statins on the kidney the evidence moves from mouse to man Nephrol Dial Transplant 19 2004 1032 1036
2. B. Afzali, A.A. Haydar, K. Vinen, D.J.A. Goldsmith From Finland to Fatland beneficial effects of statins for patients with chronic kidney disease J Am Soc Nephrol 15 2004 2161 2168
3. E.S. Schaeffner, T. Kurth, G.C. Curhan, R.J. Glynn, K.M. Rexrode, C. Baigent, J.E. Buring, J.M. Gaziano Cholesterol and the risk of renal dysfunction in apparently healthy men J Am Soc Nephrol 14 2003 2084 2091
4. G.B. Appel, J. Radhakrishnan, M.M. Avram, R.A. DeFronzo, F. Escobar-Jimenez, M.M. Campos, E. Burgess, D.A. Hille, T.Z. Dickson, S. Shahinfar RENAAL Study Investigators Analysis of metabolic parameters as predictors of risk in the RENAAL study Diabet Care 26 2003 1402 1407
5. M. Tonelli, L. Moye, F.M. Sacks, T. Cole, G.C. Curhan Cholesterol and Recurrent Events (CARE) Trial Investigators Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease J Am Soc Nephrol 14 2003 1605 1613
6. V.G. Athyros, D.P. Mikhailidis, A.A. Papageorgiou, A.N. Symeonidis, A.N. Pehlivanidis, V.I. Bouloukos, M. Elisaf The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study J Clin Pathol 57 2004 728 734
7. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification Am J Kidney Dis 3 suppl 2002 S1 S266
8. A.S. Levey, T. Greene, J. Kusek, G.J. Beck, M.S. Group A simplified equation to predict glomerular filtration rate from serum creatinine J Am Soc Nephrol 11 2000 A0828
9. L.F. Fried, T.J. Orchard, B.L. Kasiske Lipids and Renal Disease Progression Meta-Analysis Study Group Effect of lipid reduction on the progression of renal disease a meta-analysis Kidney Int 59 2001 260 269
10. D.G. Vidt, M.D. Cressman, S. Harris, J.S. Pears, H.G. Hutchinson Rosuvastatin-induced arrest in progression of renal disease Cardiology 102 2004 52 60
11. A.X. Garg, P.G. Blake, W.F. Clark, C.M. Clase, R.B. Haynes, L.M. Moist Association between renal insufficiency and malnutrition in older adults results from the NHANES III Kidney Int 60 2001 1867 1874
12. G.A. Kaysen The microinflammatory state in uremia causes and potential consequences J Am Soc Nephrol 12 2001 1549 1557
13. M.G. Shlipak, L.F. Fried, C. Crump, A.J. Bleyer, T.A. Manolio, R.P. Tracy, C.D. Furberg, B.M. Psaty Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency Circulation 107 2003 87 92
14. P.M. Ridker, C.P. Cannon, D. Morrow, N. Rifai, L.M. Rose, C.H. McCabe, M.A. Pfeffer, E. Braunwald Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 2005 20 28
15. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, T. Crowe, W.J. Sasiela, J. Tsai, J. Orazem, R.D. Magorien, C.O. O'Shaughnessy, P. Ganz Reversal of Atherosclerosis With Aggressive Lipid Lowering (REVERSAL) Investigators Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease N Engl J Med 352 2005 29 38